Cap1 analog

LZCap^®AG(3'Acm) LZCap^®AG(3'FMom) LZCap^®AG(AM) LZCap^®AG(FM) LZCap^®AU(3'Acm) LZCap^®AG(3'Ma-Biotin) LZCap^®AG(3'Ma-Peg5-FAM) LZCap^®AG(3'Ma-Cy3) LZCap^®AG(3'Ma-Cy5) LZCap^®AG(3'Ma-Cy7)

Capping kit

LZCap^®AG(3'Acm) Capping Kit LZCap^®AG(3'Acm) Capping Kit（N1-Me-pUTP）

Modified nucleotide

pUTP N1-Me-pUTP 5mCTP m6ATP 5OMeUTP N7-Methy-GTP 5mUTP 5OHmCTP 5OHmUTP ATP-αS CTP-αS GTP-αS UTP-αS EDA-ATP-MANT (3'Ome)GTP-αS (3'Ome)GTP dATP-αS Biotin-11-dUTP Biotin-16-dUTP Cy5-UTP

Nucleotide

dATP dGTP dCTP dTTP ATP GTP CTP UTP

mRNA Stock solution

LZCap^®AG(3'Acm) Firefly luc mRNA LZCap^®AG(3'Acm) eGFP mRNA LZCap^®AG(3'Acm) RFP mRNA LZCap^®AG(3'Acm) mCherry mRNA LZCap^®AG(3'Acm) RLuc mRNA LZCap^®AG(3'Acm) GLuc mRNA LZCap^®AG(3'Acm) Cas9 mRNA

Synthesis Services

Modified nucleotides Ionizable cationic lipids

ATP-αS

Cat.NO.	HN1007
Molecular Formula	C₁₀H₁₆N₅O₁₂P₃S（Free acid）
Molecular Weight	523.24（Free acid）
CAS	29220-54-0（Free acid）
Concentration	100 mM
Specifications	100 μL、1 mL
Purity	HPLC ≥95%
Salt type	TEA⁺
Storage Conditions	store at -20°C.